Shareholder alert: robbins llp reminds investors of a class action against acelrx pharmaceuticals, inc. (acrx)

San diego, california and hayward, california--(newsfile corp. - july 8, 2021) - shareholder rights law firm robbins llp reminds investors that a class action has been filed on behalf of all purchasers of acelrx therapeutics, inc. (nasdaq:acrx) securities between march 17, 2020 and february 12, 2021, against the company for remedies under the securities exchange act of 1934. acelrx is a pharmaceutical company that develops and commercializes therapies for the treatment of acute...
ACRX Ratings Summary
ACRX Quant Ranking